News

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.
WFTS Tampa, FL on MSN51m
Philip Collins | Morning Blend
Nearly nine million people in the U.S. have an inflammatory skin condition called plaque psoriasis. We're raising awareness ...
Nearly nine million people in the U.S. have an inflammatory skin condition called plaque psoriasis. We're raising awareness ...